If side effects become severe, speak to your prescriber about adjusting your treatment
The rats were dosed by s.c
At 52 weeks, the semaglutide group showed a statistically significant reduction in areal bone mineral density at the total hip (estimated treatment difference: -0.020 g/cm, p = 0.001, equating to approximately 2.6% loss) and at the lumbar spine (ETD: -0.018 g/cm, p = 0.007, approximately 2.1% loss)
Anti-obesity drug discovery: advances and challenges
It is suggested to aim for 20 to 40 grams of protein at every meal
The overall market size is expected to grow by 8X during the same period, supported by expanding treatment eligibility, increasing public reimbursement coverage, and growing clinical evidence for cardiovascular risk reduction benefits